These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 22459734)
1. Dried blood spot analysis combined with limited sampling models can advance therapeutic drug monitoring of tuberculosis drugs. Alffenaar JW J Infect Dis; 2012 Jun; 205(11):1765-6; author reply 1766. PubMed ID: 22459734 [No Abstract] [Full Text] [Related]
2. A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis. Kempker RR; Heinrichs MT; Nikolaishvili K; Sabulua I; Bablishvili N; Gogishvili S; Avaliani Z; Little BP; Bernheim A; Derendorf H; Blumberg HM; Vashakidze S; Peloquin CA Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29437945 [No Abstract] [Full Text] [Related]
3. Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis. Pranger AD; Kosterink JG; van Altena R; Aarnoutse RE; van der Werf TS; Uges DR; Alffenaar JW Ther Drug Monit; 2011 Jun; 33(3):350-4. PubMed ID: 21544017 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological issues in the treatment of tuberculosis. Peloquin CA Ann N Y Acad Sci; 2001 Dec; 953():157-64. PubMed ID: 11795409 [TBL] [Abstract][Full Text] [Related]
5. A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs. Pasipanodya JG; Gumbo T Curr Opin Pharmacol; 2011 Oct; 11(5):457-63. PubMed ID: 21807559 [TBL] [Abstract][Full Text] [Related]
6. Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis. Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Alffenaar JW; Caminero JA; Abdo Arbex M; Alarcon Guizado V; Aleksa A; Dore S; Gaga M; Gualano G; Kunst H; Payen MC; Roby Arias AJ; Skrahina A; Solovic I; Sulis G; Tadolini M; Zumla A; Migliori GB; Eur Respir J; 2016 Nov; 48(5):1503-1507. PubMed ID: 27587544 [No Abstract] [Full Text] [Related]
7. Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance. Egelund EF; Peloquin CA Clin Infect Dis; 2012 Jul; 55(2):178-9. PubMed ID: 22467672 [No Abstract] [Full Text] [Related]
9. [Consideration on the use of injectable anti-tuberculosis drufgs in the treatment of drug-resistant tuberculosis in china]. Liu YH Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):401-404. PubMed ID: 31189224 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Catanzaro DG; Trollip AP; Seifert M; Georghiou SB; Garfein RS; Rodwell TC; Catanzaro A; Eisenach KD Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28381434 [TBL] [Abstract][Full Text] [Related]
13. Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality? Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F Am J Respir Crit Care Med; 2015 Feb; 191(3):355-8. PubMed ID: 25635495 [No Abstract] [Full Text] [Related]
14. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related]
15. Is Shorter Treatment Regimen for Multidrug-resistant Tuberculosis feasible in Indian Children? Shah I Indian Pediatr; 2017 Feb; 54(2):160. PubMed ID: 28285296 [No Abstract] [Full Text] [Related]
16. Use of therapeutic drug monitoring in tuberculosis patients. Peloquin C Chest; 2004 Dec; 126(6):1722-4. PubMed ID: 15596662 [No Abstract] [Full Text] [Related]
17. Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis. van Rijn SP; Zuur MA; van Altena R; Akkerman OW; Proost JH; de Lange WC; Kerstjens HA; Touw DJ; van der Werf TS; Kosterink JG; Alffenaar JW Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137814 [TBL] [Abstract][Full Text] [Related]
18. Tuberculosis treatment and drug regimens. Sotgiu G; Centis R; D'ambrosio L; Migliori GB Cold Spring Harb Perspect Med; 2015 Jan; 5(5):a017822. PubMed ID: 25573773 [TBL] [Abstract][Full Text] [Related]
19. Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis. Zuur MA; Bolhuis MS; Anthony R; den Hertog A; van der Laan T; Wilffert B; de Lange W; van Soolingen D; Alffenaar JW Expert Opin Drug Metab Toxicol; 2016 May; 12(5):509-21. PubMed ID: 26950189 [TBL] [Abstract][Full Text] [Related]
20. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents]. Veen J Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351 [No Abstract] [Full Text] [Related] [Next] [New Search]